USCB Insider Exercise and Sale: 6,000 Shares Executed and Sold
Rhea-AI Filing Summary
Martha Guerra-Kattou, EVP Sales and Marketing of USCB Financial Holdings (USCB), reported insider option exercise and sale activity on 09/08/2025. She exercised 6,000 options with a $7.50 exercise price and received 6,000 Class A voting common shares, then sold those 6,000 shares at $16.85 each the same day. Her reported beneficial ownership fell from 43,339 shares to 37,339 shares following the transactions. The filing also discloses outstanding derivative holdings: no remaining shares from the $7.50 option after exercise and 40,000 options outstanding with a $12.05 strike expiring 09/27/2031. Several restricted stock grants are described with staggered vesting schedules (grants that include 1,770; 1,644; 20,000; and 5,907 restricted shares with various vesting commencement dates).
Positive
- Transparent reporting: Form 4 discloses exercise and sale details including prices and resulting ownership.
- Ongoing incentive alignment: Executive retains long-dated options (40,000 at $12.05) and restricted stock grants that vest over time.
Negative
- Reduced direct ownership: Beneficial ownership decreased by 6,000 shares from 43,339 to 37,339 following the reported transactions.
- Immediate sale of exercised shares: The shares obtained from the $7.50 exercise were sold the same day, indicating insider liquidity rather than added long-term share accumulation.
Insights
TL;DR: Insider exercised 6,000 options at $7.50 and sold the shares at $16.85, reducing her direct stake to 37,339 shares.
The Form 4 shows routine option exercise and immediate sale (exercise-to-cover or sell-to-cover pattern) executed on 09/08/2025. The exercise converted 6,000 options into 6,000 Class A shares, which were sold the same day at $16.85, realizing a gross spread of $9.35 per share based on the reported prices. Post-transaction holdings decreased by 6,000 shares to 37,339. Material remaining equity exposure includes 40,000 options at a $12.05 strike expiring 09/27/2031 and several restricted stock grants with multi-year vesting schedules, which will deliver shares over time. For investors, this is a disclosure of insider liquidity and ongoing incentive alignment via long-dated options and restricted stock rather than a fundamental change in ownership control.
TL;DR: Transaction appears compliant and accompanied by typical vesting schedules; no governance red flags in the filing.
The filing is signed by a power of attorney and documents both the derivative and non-derivative impacts of the 09/08/2025 transactions. Vesting schedules for several restricted stock grants are disclosed with start dates and one-third-per-year vesting mechanics, indicating standard executive compensation design. The immediate sale of shares acquired on exercise is disclosed transparently. There are no disclosures of forfeiture, transfers to affiliates, or unusual related-party arrangements in the form. This record is consistent with standard equity compensation and liquidity actions by an officer.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Options to Purchase Class A Voting Stock | 6,000 | $0.00 | -- |
| Exercise | Class A Voting Common Stock | 6,000 | $7.50 | $45K |
| Sale | Class A Voting Common Stock | 6,000 | $16.85 | $101K |
| holding | Options to Purchase Class A Voting Stock | -- | -- | -- |
Footnotes (1)
- Includes 1,770 shares of restricted stock of a grant of 2,655 shares which commenced vesting at a rate of one-third per year on January 22, 2025, 1,644 shares of restricted stock of a grant of 4,933 shares which commenced vesting at a rate of one-third per year on March 8, 2024, 20,000 of restricted stock which vest at a rate of one-third per year commencing on October 28, 2025 and 5,907 shares of restricted stock which vest at a rate of one-third per year commencing on January 21, 2026. The options vested at a rate of one-third per year commencing on January 12, 2017. The options vested at a rate of one-third per year commencing on January 22, 2022.
